Skinner

Nexcella Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

Retrieved on: 
Thursday, January 4, 2024

LOS ANGELES, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), announced that effective today, Vaishali Sanchorawala, MD, has joined the Nexcella Scientific Advisory Board.

Key Points: 
  • LOS ANGELES, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), announced that effective today, Vaishali Sanchorawala, MD, has joined the Nexcella Scientific Advisory Board.
  • I am excited to join the Nexcella team’s efforts to advance NXC-201, a promising CAR-T in relapsed/refractory AL Amyloidosis," commented Dr. Sanchorawala.
  • "Dr. Sanchorawala joining our scientific advisory board further demonstrates our leadership in relapsed/refractory AL Amyloidosis, where NXC-201 is the only CAR-T in development.
  • Dr. Sanchorawala completed residency at Rutgers Health/New Jersey Medical School and her fellowship in hematology/oncology at Boston University Medical Center.

Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

Retrieved on: 
Thursday, January 4, 2024

LOS ANGELES, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), announced that effective today, Vaishali Sanchorawala, MD, has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.

Key Points: 
  • LOS ANGELES, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), announced that effective today, Vaishali Sanchorawala, MD, has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.
  • I am excited to join the Nexcella team’s efforts to advance NXC-201, a promising CAR-T in relapsed/refractory AL Amyloidosis," commented Dr. Sanchorawala.
  • "Dr. Sanchorawala joining our scientific advisory board further demonstrates our leadership in relapsed/refractory AL Amyloidosis, where NXC-201 is the only CAR-T in development.
  • Dr. Sanchorawala completed residency at Rutgers Health/New Jersey Medical School and her fellowship in hematology/oncology at Boston University Medical Center.

Consumer Watchdog Reports: Price Gouging Penalty and Oil Refiner Accountability Bill To Become Law

Retrieved on: 
Monday, March 27, 2023

"Californians now will have a watchdog with real teeth on their side to protect them from the gouging at the gas pump that they endured during 2022," said Jamie Court, president of Consumer Watchdog.

Key Points: 
  • "Californians now will have a watchdog with real teeth on their side to protect them from the gouging at the gas pump that they endured during 2022," said Jamie Court, president of Consumer Watchdog.
  • "Californians will no longer be powerless and forced to pay $2 more than US drivers for their gasoline without recourse.
  • Armed with a price gouging penalty, California's new watchdog bureau will have the power to take action against price gouging and more importantly take precautions to deter it from occurring in the first place.
  • The bill also creates a new division of the California Energy Commission dedicated to monitoring the market on a daily basis.

Executives And Insiders At CA Big 5 Refiners Cashed Out $590 Million In Company Stock During 2022 In Wartime Profiteering, Says Consumer Watchdog

Retrieved on: 
Wednesday, March 15, 2023

29 oil executives and directors at the five oil refiners who took home more than $1 million each accounted for $231 million of the $590 million payout in 2022.

Key Points: 
  • 29 oil executives and directors at the five oil refiners who took home more than $1 million each accounted for $231 million of the $590 million payout in 2022.
  • Among the findings of Consumer Watchdog's review of SEC Form 4s:
    At Chevron alone, executives and directors cashed out $150 million worth of stock in 2022.
  • Executives at Phillips 66 took home just $4.8 million in stock sales with $3 million of that sum going to the CEO.
  • The following 29 executives at the five refiners cashed out $1 million worth of stock and up for the lion's share of $240 million in executive and director stock sales.

Consumer Watchdog Reports: PBF Energy, Last of California's Big Five Refiners To Report 2022 Results, Finishes Parade Of Windfall Profits In California

Retrieved on: 
Thursday, February 16, 2023

This is in line with its historical margin of 41 cents per gallon since it began operating in California.

Key Points: 
  • This is in line with its historical margin of 41 cents per gallon since it began operating in California.
  • Also, in the fourth quarter PBF's California margins were no longer the highest among its four regions, bucking the annual trend.
  • "We need a permanent windfall profits cap in place to deter the outrageous profit taking that California's big refiners engaged for most of 2022.
  • In 2022, all five refiners broke the 50 cent per gallon windfall profit barrier, with an average 66 cents profits per gallon for the year.

Two California Refiners Reveal Windfall Profits For 2022, Continuing In Footsteps of Chevron, Consumer Watchdog Says

Retrieved on: 
Tuesday, January 31, 2023

Meanwhile Phillips 66 reported fourth quarter West Coast results indicating a moderating influence simply from the threat of a windfall profits cap, Consumer Watchdog said today.

Key Points: 
  • Meanwhile Phillips 66 reported fourth quarter West Coast results indicating a moderating influence simply from the threat of a windfall profits cap, Consumer Watchdog said today.
  • Four out of the five big California refiners have now reported profits of $72.5 billion for the year.
  • If a windfall profits cap had been in effect in 2022, Marathon would have had to return $735 million to overcharged consumers."
  • The legislature is considering legislation, SBx1 2 (Skinner) to establish a windfall profits cap on how much oil refiners can make in profit per gallon of gasoline.

Chevron Reports $1.4 Billion In CA Windfall Refining Profits In 2022, Total Windfall Profits Rebate Climbs to $3.2 Billion As Fourth Quarter Reports Continue To Roll In, Consumer Watchdog Says

Retrieved on: 
Monday, January 30, 2023

Chevron has only crossed the 50 cents per gallon profit level three times in the last twenty years.

Key Points: 
  • Chevron has only crossed the 50 cents per gallon profit level three times in the last twenty years.
  • If California had set a windfall profits cap at 50 cents for 2022, Chevron would owe California consumers a $1.4 billion rebate for its excessive profits in 2022, according to a calculation by Consumer Watchdog.
  • "The oil refiners' profit reports show that this year's Golden State Gouge was at pig-at-the-trough levels," said Jamie Court, president of Consumer Watchdog.
  • ( See slide 10 )
    With three refiners' profits reports outstanding, California oil refiners would owe consumers $3.2 billion in windfall profit rebates, or about $128 per driver, Consumer Watchdog said.

Chevron Doubles 2022 Profits, Reveals Extensive Gas Price Gouging In The West, Consumer Watchdog Says

Retrieved on: 
Friday, January 27, 2023

West Coast refining margins were a startling 85 cents per gallon for 2022, doubling last year's margin of 37 cents per gallon.

Key Points: 
  • West Coast refining margins were a startling 85 cents per gallon for 2022, doubling last year's margin of 37 cents per gallon.
  • Consumer Watchdog has suggested penalties kick in after 50 cents per gallon.
  • "Chevron's profit reports are the poster child for why we need a price gouging penalty on excessive profits," said Jamie Court, President of Consumer Watchdog.
  • "The price gouging penalty under consideration by California lawmakers will go hand-in-hand with those reporting requirements and is vital to enact," said Consumer Advocate Liza Tucker.

Millennium Solutions recruits Sales Leader for Pactum AI – a Chat Negotiation AI Company

Retrieved on: 
Tuesday, December 20, 2022

Millennium Solutions, one of the worlds premiere technology recruiting firms, has recruited Scott Mars to Pactum AI as the new Vice President of Sales.

Key Points: 
  • Millennium Solutions, one of the worlds premiere technology recruiting firms, has recruited Scott Mars to Pactum AI as the new Vice President of Sales.
  • Steven Skinner, Founder of Millennium Solutions and responsible for the key hire, is very optimistic about the Negotiation AI software company.
  • Skinner’s latest client joins an impressive list of Machine Learning and AI companies including UiPath which he signed in 2016.
  • (Photo: Business Wire)
    Steven Skinner, CEO of Millennium Solutions, said, “With Scott Mars as the new Sales Leader, Pactum AI has a competitive advantage with speed to market by building a world class sales organization.

REPAY Hires Erik Skinner as Senior Vice President of the Mortgage Vertical

Retrieved on: 
Tuesday, September 13, 2022

Repay Holdings Corporation (NASDAQ: RPAY) (REPAY), a leading provider of vertically-integrated payment solutions, today announced the addition of Erik Skinner as Senior Vice President, Mortgage Vertical Executive.

Key Points: 
  • Repay Holdings Corporation (NASDAQ: RPAY) (REPAY), a leading provider of vertically-integrated payment solutions, today announced the addition of Erik Skinner as Senior Vice President, Mortgage Vertical Executive.
  • In his new role, Skinner will focus on enhancing REPAYs mortgage offerings through business development opportunities and strategic product development.
  • Prior to joining REPAY, Skinner served as Senior Vice President, Servicing Product Strategy Director, at Black Knight, Inc., where he was responsible for MSP and back-office customer experience modernization.
  • Before Black Knight, Skinner served as Senior Vice President of Performing Mortgage Servicing at Fifth Third Bank, after serving as Vice President of Customer Advocacy at PHH.